跳至主要内容
临床试验/NCT06052540
NCT06052540进行中(未招募)不适用

Effetto Della Supplementazione di Una Miscela di Ceppi Probiotici (Bifidobacterium Breve M-16V, Bifidobacterium Lactis HN019, Lactobacillus Rhamnosus HN001) in Bambini Febbrili Con Infezioni Delle Alte Vie Respiratorie

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico2 个研究点 分布在 1 个国家目标入组 128 人开始时间: 2021年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
128
试验地点
2
主要终点
Mean duration of fever in days by measuring body temperature

研究概览

简要总结

The goal of this randomized non-pharmacological Intervention study is to evaluate the effects of probiotic supplements (Bifidobacterium breve M-16V, Bifidobacterium lactis HN019, Lactobacillus rhamnosus HN001) on children affected by upper respiratory tract infections.

The main questions it aims to answer are:

  • probiotic formulation can reduce intensity and duration of fever in children affected by upper respiratory tract infections
  • probiotic formulation can influence the gut microbiota composition in children affected by upper respiratory tract infections

Participants will be asked to take probiotic supplements or placebo for 14 days and to collect three fecal samples: before probiotic supplementation (T0), 14 days after probiotic supplementation (T1), and 12 months after the enrollment (T2).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
29 Days 至 4 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Access to the Emergency room with fever and upper respiratory tract infection
  • Age > 28 days and ≤ 4 years
  • Signature of informed consent by parents or guardian

排除标准

  • Presence of pathologies associated with immunosuppression or ongoing immunosuppressant treatments
  • Hospitalisation/hospitalisation
  • Diarrhea at enrollment
  • No signed informed consent

结局指标

主要结局

Mean duration of fever in days by measuring body temperature

时间窗: Approximatively 7 days

To assess the effects of a probiotic supplement compaerd to a placebo on mean duration and intensity of fever measured by a thermometer

次要结局

  • Adverse events(Approximatively 15 days)
  • Gastrointestinal symptoms(Approximatively 7 days)
  • Mean change in gut microbial composition by measuring gut microbiota characterization in fecal samples(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Cristiana Berti

Researcher

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

研究点 (2)

Loading locations...

相似试验